Alexandria University Hospitals
Alexandria, Alexandria Governorate, 110226, Egypt
NCT Number: NCT00794053
Detection of lymph nodes starting to be involved by cancer spreading from the thyroid gland during operation is useful. It saves the patient from having a second operation to remove these nodes later on when they become obvious. The problem is that there are many lymph nodes around the gland. The theory is that only one node will get the first spill of the tumour cells.
In this study the investigators are trying to use an inert colored material to inject into the tumour. This should run in the same path as the tumour cells and should therefore stain the one lymph node that will be affected first should the tumour spread.
The stained lymph node is excised and examined instantaneously for tumour affection. If it is found to be affected by the tumour, then the operation is extended to include removal of all its fellow lymph nodes. If it is found to be free from the tumour, then this patient does not have tumour spread.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 3
Alexandria, Alexandria Governorate, 110226, Egypt
The study includes 45 consecutive patients diagnosed as differentiated thyroid cancer by clinical examination and/or fine needle aspiration cytology (FNAC).
Exclusion criteria
are: previous neck surgery, pregnancy and known hypersensitivity to the dye used.
An informed consent was obtained from all the patients. Peroperative workup includes history taking, clinical examination, relevant laboratory investigations including thyroid hormone assay, ultrasonography of the neck with special emphasis on the thyroid focal lesion and cervical lymph nodes. FNAC was attempted in all patients.
All patients were then subjected to operation:
A systematized surgical approach was adopted for the purpose of the study: this started by collar incision, development of sub-platysmal skin flaps and separation of strap muscles in the midline. This was followed by exposure of the thyroid gland; identification of the thyroid tumour; injection of the dye into the tumour; waiting for the dye to reach the lymph nodes; identifying the stained node; labeling it as the sentinel node (SLN); performing total thyroidectomy and bilateral central neck dissection.
The resected specimen was fixed by formaldehyde, stained with hematoxylin and eosin and examined with light microscopy.
If the SLN was found to be free of malignant deposits, it was further examined by immunohistochemical staining.
Statistical analysis: Descriptive statistics were used to analyze demographic data. Sensitivity, specificity and predictive value of the SLN were calculated.
The histopathological report of the excised specimen was considered the criterion standard.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
this started by collar incision, development of sub-platysmal skin flaps and separation of strap muscles in the midline. This was followed by exposure of the thyroid gland; identification of the thyroid tumour; injection of the dye into the tumour; waiting for the dye to reach the lymph nodes; identifying the stained node; labeling it as the sentinel node (SLN); performing total thyroidectomy and bilateral central neck dissection.
Other names: sentinel lymph node detection, staging of thyroid cancer
Time frame: the lymph nodes removed during the surgery will be examined the next day of the operation
University of Alexandria
Other
The Role of Sentinel Lymph Node Biopsy (SLNB) In the Management of Differentiated Thyroid Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06439745
Adenocarcinoma, Adenocarcinoma, Papillary
View Trial DetailsNCT06793579
Endocrine Gland Neoplasms, Endocrine System Diseases
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT04274829
Endocrine Gland Neoplasms, Endocrine System Diseases
Cagliari, CA, Italy
View Trial DetailsNCT00795782
Adenocarcinoma, Adenocarcinoma, Papillary
Seoul, South Korea
View Trial Details